Evidence map›Paper›PMID 40147505›Full record

ArticleAmerican journal of preventive medicine2025

Partner Violence and Substance-Related Service Use: Differences by HIV Status Among Women.

Shannon N Ogden, Paul R Shafer, Melissa E Dichter, Jack A Clark, Mirjam-Colette Kempf, Deborah L Jones, Gina M Wingood, Aruna Chandran, Mardge H Cohen, Jennifer P Jain and 4 more

Abstract read
In one paragraph

Article in American journal of preventive medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Shannon N OgdenDivision of Research, Kaiser Permanente Northern California, Pleasanton, California; Department of Health Policy, Law, & Management, Boston University School of Public Health, Boston, Massachusetts. Electronic address: Shannon.N.Ogden@kp.org.
Paul R ShaferDepartment of Health Policy, Law, & Management, Boston University School of Public Health, Boston, Massachusetts.
Melissa E DichterDepartment of Veterans Affairs, Center for Health Equity Research and Promotion, Crescenz VA Medical Center, Philadelphia, Pennsylvania; School of Social Work, Temple University College of Public Health, Philadelphia, Pennsylvania.
Jack A ClarkDepartment of Health Policy, Law, & Management, Boston University School of Public Health, Boston, Massachusetts.
Mirjam-Colette KempfSchools of Nursing Public Health and Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
Deborah L JonesDepartment of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, Florida.
Gina M WingoodDepartment of Sociomedical Sciences, Columbia University Mailman School of Public Health, New York, New York.
Aruna ChandranDepartment of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.
Mardge H CohenDepartment of Medicine, John H. Stroger Jr Hospital of Cook County, Chicago, Illinois.
Jennifer P JainDepartment of Community Health Systems, School of Nursing, University of California, San Francisco, California.
Lakshmi GoparajuSchool of Medicine, Georgetown University Medical Center, Washington, District of Columbia.
Tracey E WilsonDepartment of Community Health Sciences, School of Public Health, State University of New York, Downstate Health Sciences University, Brooklyn, New York.
Adebola AdedimejiDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York.
Danielle F HaleyDepartment of Community Health Sciences, Boston University School of Public Health, Boston, Massachusetts.

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Paul A. Goepfert · 1988 to 2026
$84.1M
Engaging University of California Stakeholders for Biorespository ResearchUL1TR000004 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANDIS, JENNIFER RUBIN · 2012 to 2015
$78.0M
Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0M
QAQC Johns Hopkins Institute for Clinical and Translational ResearchUL1TR003098 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2019 to 2023
$57.7M
Maternal Morbidity and Mortality: Risk Factors, Early Detection and Personalized InterventionUL1TR001409 · NCATS · GEORGETOWN UNIVERSITY · PI GONDRE-LEWIS, MARJORIE C, MELLMAN, THOMAS A · 2015 to 2024
$37.8M
SF Bay Area MACS/WIHS Combined Cohort StudyU01HL146242 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Bradley E Aouizerat, Jennifer Cohen Price · 2019 to 2026
$36.3M
Sex differences in the role of multi-omicsin HIV-associated carotid artery atherosclerosisU01HL146193 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Stephen J Gange, Elizabeth Topper · 2019 to 2026
$35.8M
University of Miami Developmental Center for AIDS Research (D-CFAR)P30AI073961 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Savita Pahwa · 2007 to 2026
$33.8M
Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center - Admin Supplement: Vision and dual sensory loss in HIV-infected older adultsU01HL146201 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI TODD T BROWN, Joseph B. Margolick · 2019 to 2026
$33.7M
Sex differences in the role of multi-omics in HIV-associated carotid artery atherosclerosisU01HL146204 · NHLBI · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI David B. Hanna, Anjali Sharma · 2019 to 2026
$33.2M
NCATS NIH HHS KL2 TR001432NCATS NIH HHS TL1 TR001431NCATS NIH HHS UL1 TR000004NCATS NIH HHS UL1 TR001409NCATS NIH HHS UL1 TR001881NCATS NIH HHS UL1 TR003098NHLBI NIH HHS U01 HL146192NHLBI NIH HHS U01 HL146193NHLBI NIH HHS U01 HL146194NHLBI NIH HHS U01 HL146201NHLBI NIH HHS U01 HL146202NHLBI NIH HHS U01 HL146203NHLBI NIH HHS U01 HL146204NHLBI NIH HHS U01 HL146205NHLBI NIH HHS U01 HL146208NHLBI NIH HHS U01 HL146240NHLBI NIH HHS U01 HL146241NHLBI NIH HHS U01 HL146242NHLBI NIH HHS U01 HL146245NHLBI NIH HHS U01 HL146333NIAID NIH HHS P30 AI027767NIAID NIH HHS P30 AI050409NIAID NIH HHS P30 AI050410NIAID NIH HHS P30 AI073961NIDA NIH HHS K01 DA046307NIDA NIH HHS K01 DA056306NIDA NIH HHS T32 DA041898NIMH NIH HHS P30 MH116867
6 · The paper itself

Abstract

introductionSubstance use disorders are prevalent among women living with HIV and women experiencing intimate partner violence. The study aimed to examine the association between intimate partner violence and substance-related service utilization among women living with and without HIV.

methodsUtilizing Women's Interagency HIV Study (2013-2019) data, linear regression models in 2023-2024 estimated the association between recent and lifetime intimate partner violence and drug- and alcohol-related service utilization among women reporting substance use. Adjusted models included an interaction between intimate partner violence and HIV status, time-variant covariates, person-level fixed effects, and standard errors clustered at the individual level.

resultsAmong 1,550 participants, 40% had a baseline history of intimate partner violence and 67% were living with HIV. Any recent intimate partner violence and recent psychological intimate partner violence were associated with increased alcohol-related service utilization (aβ=0.039, 95% CI=0.002, 0.076; aβ=0.042, 95% CI=0.002, 0.083; respectively). Recent sexual intimate partner violence was associated with increased drug- (aβ=0.082, 95% CI=0.000, 0.165) and alcohol-related (aβ=0.131, 95% CI=0.028, 0.233) service utilization. Those living with HIV who had experienced recent sexual intimate partner violence were less likely to utilize drug- (aβ= -0.143, 95% CI= -0.249, -0.037) and alcohol-related services (aβ= -0.122, 95% CI= -0.237, -0.007). Any lifetime intimate partner violence and lifetime psychological intimate partner violence were associated with decreased alcohol-related service use (aβ= -0.097, 95% CI= -0.169, -0.025; aβ= -0.096, 95% CI= -0.171, -0.020; respectively).

conclusionsFindings highlight the complex relationship between intimate partner violence and substance use disorder service utilization and differences of living with HIV on substance-related service utilization among women. Implementing a trauma-informed approach to address intimate partner violence, HIV, and substance use in healthcare settings could improve substance use disorder-related service utilization and outcomes, and overall well-being among women.

Indexed as

HIV InfectionsIntimate Partner ViolenceSubstance-Related DisordersAdultFemaleHumansMiddle AgedUnited States

Identifiers

PMID40147505
PMCPMC12092184

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.